2025, Número 3
Siguiente >>
Cir Card Mex 2025; 10 (3)
El paradigma en evolución del Heart Team: desafíos y oportunidades
García-Villarreal OA, Calderón-Abbo MC
Idioma: Ingles.
Referencias bibliográficas: 7
Paginas: 77-78
Archivo PDF: 488.54 Kb.
REFERENCIAS (EN ESTE ARTÍCULO)
Head SJ, Davierwala PM, Serruys PW, et al. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Eur Heart J. 2014;35(40):2821-2830. doi: 10.1093/eurheartj/ehu213.
Vahanian A, Beyersdorf F, Praz F, et al; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561-632. doi: 10.1093/eurheartj/ehab395.
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932.
Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(3):e18-e114. doi: 10.1161/CIR.0000000000001038.
Pavlidis AN, Perera D, Karamasis GV, et al. Implementation and consistency of Heart Team decision-making in complex coronary revascularisation. Int J Cardiol. 2016;206:37-41. doi: 10.1016/j.ijcard.2016.01.041.
Patterson T, McConkey HZR, Ahmed-Jushuf F, et al. Long-Term outcomes following heart team revascularization recommendations in complex coronary artery disease. J Am Heart Assoc. 2019;8(8):e011279. doi: 10.1161/JAHA.118.011279.
Calderón-Abbo MC, Carrillo-Cornejo M, Lara L, Arias-Rivera SA. Practical guidelines for aortic valve surgery and the current role of the Heart Team. Case report. Cir Card Mex. 2025;10(3):92-94.